Stefan Wilop

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.6K citations · Full text

Medicine, Pathology, Head And Neck Cancer +5

Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

Ulrich Dührsen, Stefan Müller, Bernd Hertenstein et al. · Journal of Clinical Oncology · 2018 · 238 citations

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

Stefan Wilop, Sabine von Hobe, Martina Crysandt et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 161 citations · Full text

Medicine, Pharmacology, Bronchial Neoplasm +8

DNA methylation changes in multiple myeloma

Oliver Galm, Stefan Wilop, Julia Reichelt et al. · Leukemia · 2004 · 127 citations

Dna Methylation Changes, Chromatin, Epigenetic Change +6

A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR

Rainer Claus, Stefan Wilop, Thomas Hielscher et al. · Epigenetics · 2012 · 84 citations · Full text